Patent Law Weblog
recent posts
- Apple v. Squires: USPTO Director Has Unlimited Discretion on IPR Institution
- The Ghost in the Machine: Why GenAI Can Be Both a Brilliant Researcher and a Terrible Advocate
- Bayer Files Suit Against Trio of COVID-19 Vaccine Makers
- Allen v. Cooper (4th Cir. 2026)
- To Require an Inventor ID, or Not to Require an Inventor ID – That Is the Question
about
Month: May 2009
-
By Andrew Williams — Last Thursday, the Federal Circuit affirmed the decision of the District Court for the District of New Jersey denying a request by Altana Pharma and Wyeth (collectively "Altana") for a preliminary injunction to prevent Teva Pharmaceuticals ("Teva") from marketing a generic version of the antiulcer drug Protonix®. The active ingredient…
-
By Kevin E. Noonan — The lawsuit filed by plaintiffs and represented by lawyers from the American Civil Liberties Union and the Public Patent Foundation (PUBPAT) is easy to decry in the biotechnology patent community. Patent Docs will provide a detailed explication of the complaint, including a discussion of its many falsehoods, misstatements and…
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases, and a few interesting cases will be selected for periodic monitoring. Genzyme Corp. v. Lupin Ltd. et al.1:09-cv-01258; filed May 14, 2009 in the District Court of Maryland Infringement of U.S. Patent Nos.…
-
May 18-21, 2009 – BIO International Convention (Biotechnology Industry Organization) – Atlanta, GA May 20, 2009 – Tafas v. Doll — Dissecting the Decision and Preparing for Resurgence of USPTO Rules Limiting Patent Claims*** (American Conference Institute) – 1:00-2:30 PM (EST) May 27, 2009 – Follow-on Biologics Patent Litigation: Using Additional Patents and REMS to…
-
FDA News will be offering a webinar entitled: "Follow-on Biologics Patent Litigation: Using Additional Patents and REMS to Protect Market Share" on May 27, 2009 from 11:00 am to 12:30 pm (EST). Chad Landmon and Matt Becker of Axinn, Veltrop & Harkrider LLP will provide a comparison of competing follow-on biologics legislation and demonstrate the…
-
The National Association of Patent Practitioners (NAPP) will be holding its 2009 Annual Meeting on July 18-21, 2009 in San Diego, CA. An optional short-course entitled: "The Nuts & Bolts of Patent Prosecution Practice" will be offered on July 18. Topics to be covered during the short course include: • Inventorship • Prior Art Searching…
-
"Biotech/Pharma" Top 43 By Donald Zuhn — The Intellectual Property Owners Association (IPO) released its 26th annual list of the top 300 organizations receiving U.S. patents. Patent Docs Readers may recall that the U.S. Patent & Trademark Office stopped releasing its annual list of top patent recipients in 2006 in order to "discourag[e] any…
-
By Donald Zuhn — The Federal Circuit today affirmed a determination by the District Court for the District of Delaware that U.S. Patent No. 5,583,122 was not invalid as obvious nor invalid for obviousness-type double patenting. The '122 patent, which is owned by Plaintiff-Appellee Procter & Gamble Co. (P&G), relates to the compound risedronate,…
-
By Kevin E. Noonan — Association for Molecular Pathology et al. v. U.S. Patent and Trademark Office, Myriad Genetics et al.09-cv-04515-RWS; filed May 12, 2009 in the District Court for the Southern District of New York Earlier today, a group of patients, physicians, academic researchers and medical societies filed suit in the Southern District…
-
By Donald Zuhn — On April 30th, the House Committee on the Judiciary heard testimony from seven witnesses (and accepted written testimony from other interested parties) regarding the House patent reform bill (H.R. 1260) (see "House Judiciary Committee Holds Hearing on Patent Reform"). Part I of our coverage of the hearing examined written testimony…
Patent Docs 